CTA Characterization of Vulnerable Plaque Minneapolis Heart Institute

Slides:



Advertisements
Similar presentations
Implications from PROSPECT and Future Directions Gregg W. Stone, MD Columbia University Medical Center The Cardiovascular Research Foundation Providing.
Advertisements

IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
PBL CV 2 Pathophysiology of coronary artery disease.
Coronary Artery Calcification & Computed Tomography Scoring.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Electron Beam Tomography EBT. I’ve never heard of it, (and it doesn’t sound good) Electrons –Atomic particles –Have mass Wouldn’t a beam of particulate.
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT Saving Our Law Officers From Sudden Death and Heart Attacks.
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Virtual Histology:From Theory to Vulnerable Plaque Detection Shaoliang Chen MD Nanjing First Hospital Nanjing Cardiovascular Hospital.
Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality Khurram Nasir MD MPH, Leslee J. Shaw PhD, Sandy T.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Ravi Doobay and Dr. Eric Harrison We care about the health of our firefighters Tampa Fire Rescue: Saving our Firefighters from Heart Disease.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
New techniques for the “invasive diagnosis” of the vulnerable plaque Antwerp, 17 March 2006.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
CARDIAC CT IN SCREENING FOR CAD Hossein Nademi MD CARDIOLOGIST JAVADOL-A-EME HEART HOSPITAL OCT
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coronary Computed Tomography Angiography as a Screening.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Detection of Coronary Artery Stenoses by Low-Dose,
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Assessment of Coronary Plaque Progression in Coronary.
R4 하 상 진. Introduction Circulation May 1;115(17):
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Intracoronary Transluminal Attenuation Gradient in.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Multidetector Coronary Computed.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Are the Culprit Lesions Severely Stenotic? J Am Coll.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparison of Electron Beam Computed Tomography.
Matthew P. Ostrom, MD, Ambarish Gopal, MD, Naser Ahmadi, MD, Khurram Nasir, MD, MPH, Eric Yang, MD, Ioannis Kakadiaris, PHD, Ferdinand Flores, BS, Song.
Ischaemic heart disease. Coronary artery disease(CAD) is the leading cause of death worldwide. The rates of mortality and disability due to CAD are increasing.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Total Occlusion Study of Canada (TOSCA-2) Trial
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,
Disclosure Statement of Financial Interest
It’s Both the Vulnerable Patient and the Vulnerable Plaque
The American College of Cardiology Presented by Dr. Steven E. Nissen
Atherosclerosis and HDL Therapy New Virtual Histology Findings
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Use of OCT to Localize Macrophages
CT for Evaluation & Treatment of Cardiovascular Disease
The Role of Inflammation and Immune Responses
Should we Use OCT in STEMI Patients?
Clinical need for determination of vulnerable plaques
Near Infrared Spectroscopy: Case Studies and Clinical Relevance
The Role of Cardiac CT in Women
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
On behalf of J. Belardi, M. Leon, L. Mauri,
Imaging the event-prone coronary artery plaque
Case of nonobstructive coronary artery disease of left anterior descending artery (LAD) and regional LV dysfunction detected on cardiac CT with subsequent.
Coronary Computed Tomographic Angiography
William Insull, MD  The American Journal of Medicine 
American College of Cardiology Presented by Dr. Stephan Windecker
Giuseppe Biondi Zoccai, MD
Volume 383, Issue 9918, Pages (February 2014)
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Bioresorbable Vascular Scaffolds in Cardiac Allograft Vasculopathy: A New Therapeutic Option  Flavio Ribichini, MD, Michele Pighi, MD, Giuseppe Faggian,
CT coronary angiography and coronary calcium scoring
Correlation between endothelial function and hypertension
Presented at TCT 2006.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Maintenance of Long-Term Clinical Benefit with
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
Figure 3 Imaging of adverse plaque characteristics
Francesco Prati et al. JIMG 2013;6:
Nat. Rev. Cardiol. doi: /nrcardio
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
The American College of Cardiology Presented by Dr. A. Abazid
James A. Goldstein et al. JIMG 2008;1:
The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment William Insull, Jr, MD Professor of Medicine and Pediatrics,
Presentation transcript:

CTA Characterization of Vulnerable Plaque Minneapolis Heart Institute Robert S. Schwartz, MD Minneapolis Heart Institute

Shareholder/Founder: Atritech Robert S. Schwartz, MD Shareholder/Founder: Atritech

What is a Vulnerable Plaque? Plaque morphology underlying luminal thrombi represents a vulnerable plaque Thin-cap Fibroatheroma – Plaque rupture Pathologic intimal thickening Fibroatheroma Calcified plates with bone formation – Calcified nodule - surface thrombus Plaque Erosion

Causes of Coronary Thrombosis Virmani R, et al. Arterioscler Thromb Vasc Biol 2000;20:1262 Erosion Rupture Calcified nodule Rupture Site Calcified Nodule NC Th Th Th Th NC FC Th Th Th Th

Whither Coronary Calcification ? 5

Very High Coronary Artery Calcium Scores: Extremely Elevated Risk Wayhs R, Zelinger A, Raggi P, JACC 2002;39:225-230 Probability of survival free of events in 98 consecutive asymptomatic subjects with calcium score >1,000 on a screening electron beam tomography scan. 6

Risk of MI Raggi et al. Arterioscler Thromb Vasc Biol 2004;24:1272 Progressors were 17 fold more likely to have a hard cardiac event 7

Event rates relative to Framingham Risk 632 aSx pts Raggi, Am Heart J 2001;141:376 8

Incremental Value of CAC Over Total Risk Factors Budoff, M. J. et al. J Am Coll Cardiol 2007;49:1860-1870

Consecutive Acute MIs at BWH (n=200) Location of MI by Vessel Kuntz et al Consecutive Acute MIs at BWH (n=200)

Distribution of Acute Coronary Occlusions Left Anterior Descending Artery (Normalized Segment Analysis) 35 30 p = 0.003 25 33.3 20.5 20 Percent (%) 16.7 16.7 15 10 6.4 5 3.9 1.3 1.3 10 20 30 40 50 60 70 80 90 100 110 120 130 millimeters (mm) Prox Mid Distal 11

Cumulative Frequency Distribution Distance from Ostium LAD 100 80 60 Percent (%) 40 20 10 20 30 40 50 60 70 80 millimeters (mm) 12

MSCTA: Disease is Proximal There are only a handful of radioisotopes with characteristics suitable for coronary Brachytherapy applications. Radioactive isotopes have a fixed half-life (the time it takes for the activity to drop by half). Their energies are also fixed. These energies are dictated by the nuclear structure and cannot be altered. Therefore to reach a certain target with radioisotopes one must have the right energy. If the conditions between the isotope and the target are changed by the presence of foreign material with different properties than tissue the dose to the target may not be achieved. As I mentioned earlier, beta sources have a limited depth of penetration which is adequate for a millimeter depth. On the other hand due to gamma's penetrating power it delivers a dose well beyond the treatment zone. 13

Gregg W. Stone, MD PROSPECT Investigators 9/11/2018 The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque This is the Main Title Slide There is no Master for this particular slide, as it is used only once for each presentation. To use this slide in your presentation, merely retype the title and the list of participating doctors. Gregg W. Stone, MD PROSPECT Investigators TCT 2008 - DRAFT 14 14

PROSPECT: Conclusions Approximately 20% of pts with successfully treated ACS with stents and medical Rx develop MACE within 3 years Adverse future events are equally attributable to recurrence at originally treated culprit lesions (treatment failure) and to previously untreated coronary segments Approximately 12% of pts develop MACE from non culprit lesions during 3 years of follow-up Patients treated with medical therapy who develop non culprit lesion events present most commonly with progressive or unstable angina, and rarely with cardiac death, cardiac arrest or MI

PROSPECT: Conclusions While plaques responsible for unanticipated future MACE are angiographically mild, most untreated plaques which become symptomatic have a large plaque burden and a small lumen area (which are detectable by IVUS but not by angiography) Only about half of new events due to non culprit lesions exemplify the classic notion of vulnerable plaque (rapid lesion progression of mild angiographic lesions), while half are attributable to unrecognized and untreated severe disease with minimal change over time

PROSPECT: Conclusions The prospective identification of non culprit lesions prone to develop MACE within 3 years can be enhanced by characterization of underlying plaque morphology with virtual histology, with VH-TCFAs representing the highest risk lesion type The combination of large plaque burden (IVUS) and a large necrotic core without a visible cap (VH-TCFA) identifies lesions which are at higher risk for future adverse cardiovascular events

Characterization of Noncalcified Coronary Plaques and Identification of Culprit Lesions in Patients With Acute Coronary Syndrome by 64-Slice Computed Tomography Toshiro Kitagawa et al Objectives: We sought to characterize noncalcified coronary atherosclerotic  plaques in culprit and remote coronary atherosclerotic lesions in patients with acute coronary syndrome (ACS) with 64-slice computed tomography (CT). Background: Lower CT density, positive remodeling, and adjacent spotty coronary calcium are characteristic vessel changes in unstable coronary plaques. Methods: Of 147 consecutive patients who underwent contrast-enhanced 64-slice CT examination for coronary artery visualization, 101 (ACS; n = 21, non-ACS; n = 80) having 228 noncalcified coronaryatherosclerotic plaques (NCPs) were studied. Each NCP detected within the vessel wall was evaluated by determining minimum CT density, vascular remodeling index (RI), and morphology of adjacent calcium deposits. Results: The CT visualized more NCPs in ACS patients (65 lesions, 3.1 ± 1.2/patient) than in non-ACS patients (163 lesions, 2.0 ± 1.1/patient). Minimum CT density (24 ± 22 vs. 42 ± 29 Hounsfield units [HU], p < 0.01), RI (1.14 ± 0.18 vs. 1.08 ± 0.19, p = 0.02), and frequency of adjacent spotty calcium of NCPs (60% vs. 38%, p < 0.01) were significantly different between ACS and non-ACS patients. Frequency of NCPs with minimum CT density <40 HU, RI >1.05, and adjacent spotty calcium was approximately 2-fold higher in the ACS group than in the non-ACS group (43% vs. 22%, p <0.01). In the ACS group, only RI was significantly different between 21 culprit and 44 nonculprit lesions (1.26 ± 0.16 vs. 1.09 ± 0.17, p < 0.01), and a larger RI ( 1.23) was independently related to the culprit lesions (odds ratio: 12.3; 95% confidential interval: 2.9 to 68.7, p < 0.01), but there was a substantial overlap of the distribution of RI values in these 2 groups of lesions.

Comparison of RI Between ACS Culprit and Nonculprit Lesions Kitagawa, T. et al. J Am Coll Cardiol Img 2009;2:153-160 Copyright ©2009 American College of Cardiology Foundation. Restrictions may apply.

Gold NanoParticles for Vulnerability Cormode et al Radiology August 2010

Multislice Computed Tomographic Characteristics of Coronary Lesions in Acute Coronary Syndromes Motoyama JACC, 50:4, 24 July 2007, p319-326 295 ACS vs 149 SAP Abstract: ObjectivesTo evaluate the feasibility of noninvasive assessment of the characteristics of disrupted atherosclerotic plaques, the authors interrogated the culprit lesions in acute coronary syndromes (ACS) by multislice computed tomography (CT).BackgroundDisrupted atherosclerotic plaques responsible for ACS histopathologically demonstrate large lipid cores and positive vascular remodeling. It is expected that plaques vulnerable to rupture should bear similar imaging signatures by CT.MethodsEither 0.5-mm × 16-slice or 64-slice CT was performed in 38 patients with ACS and compared with 33 patients with stable angina pectoris (SAP) before percutaneous coronary intervention. The coronary plaques in ACS and SAP were evaluated for the CT plaque characteristics, including vessel remodeling, consistency of noncalcified plaque (NCP <30 HU or 30 HU <NCP <150 HU), and spotty or large calcification.ResultsIn the CT profile of culprit ACS and SAP lesions, the frequency of 30 HU <NCP <150 HU (100% vs. 100%, p = NS) was not different, and large calcification (22% vs. 55%, p = 0.004) was significantly more frequent in the stable lesions. Positive remodeling (87% vs. 12%, p < 0.0001), NCP <30 HU (79% vs. 9%, p < 0.0001), and spotty calcification (63% vs. 21%, p = 0.0005) were significantly more frequent in the ACS lesions. Presence of all 3 (i.e., positive remodeling, NCP <30 HU, and spotty calcification) showed a high positive predictive value, and absence of all 3 showed a high negative predictive value for the culprit plaques associated with ACS. Conclusion: CT characteristics of plaques associated with ACS include positive vascular remodeling, low plaque density, and spotty calcification. It is logical to presume that plaques vulnerable to rupture harbor similar characteristics.

Uncalcified Plaque 124 pts Calcium Score Zero 45% No Plaque 55% with Noncalcified plaque only 55% NCP Only

Risk Factor Assessment No NCP Normal Cors n (%) NCP Mild stenosis Mod-severe stenosis P Value Number of patients 55 (44.4) 63 (50.8) 6 (4.84) Female 36 (65.5) 36 (57.1) 4 (66.7) ns Age (avg +/- SD) 50.2 +/- 11.8 50.7 +/- 11.6 49.8 +/- 8.4 Family history of CHD 32 (58.2) 47 (74.6) 5 (83.3) Hyperlipidemia 43 (68.3) Curr / Former smoker 9 (16.4) 26 (41.3) 0.023* Diabetes Mellitus 1 (1.82) 3 (4.76) 1 (16.7) HTN 15 (27.3) 27 (42.9) Obesity (BMI ≥ 27) 25 (45.5) 34 (54.0) 6 (100) *No NCP vs (NCP mild stenosis + NCP sig stenosis)

59 yo male with Sudden Cardiac Death 11 months post CTA

Importance of Remodeling Remodeling Index ~ 1.40 HU ~60

CTA Characterization of Vulnerable Plaque Minneapolis Heart Institute Robert S. Schwartz, MD Minneapolis Heart Institute 26